Skip to main content

Computed Tomography

1
Pipeline Programs
3
Companies
7
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Bayer
BayerLEVERKUSEN, Germany
2 programs
1
Iopromide 370 mg I/mLPhase 31 trial
Centargo injectorN/A1 trial
Active Trials
NCT03875469Completed425Est. Mar 2020
NCT00244140Completed435Est. Apr 2008
Philips
PhilipsNetherlands - Amsterdam
5 programs
Clinical Study for P-MARN/A1 trial
Precise 3D SurviewN/A1 trial
Precise Image for Interventional CTN/A1 trial
Precise Image for Musculoskeletal CTN/A1 trial
Precise Image for PediatricsN/A1 trial
Active Trials
NCT07317479Not Yet Recruiting120Est. Oct 2026
NCT07267533Not Yet Recruiting274Est. Oct 2026
NCT07317427Not Yet Recruiting55Est. Oct 2026
+2 more trials

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
BayerIopromide 370 mg I/mL
PhilipsPrecise 3D Surview
PhilipsPrecise Image for Interventional CT
PhilipsPrecise Image for Musculoskeletal CT
PhilipsClinical Study for P-MAR
PhilipsPrecise Image for Pediatrics
BayerCentargo injector

Clinical Trials (7)

Total enrollment: 1,561 patients across 7 trials

NCT00244140BayerIopromide 370 mg I/mL

Ultravist: Safety and Efficacy in Computed Tomography of Head and Body

Start: Oct 2005Est. completion: Apr 2008435 patients
Phase 3Completed
NCT07267533PhilipsPrecise 3D Surview

Precise 3D Surview

Start: Jan 2026Est. completion: Oct 2026274 patients
N/ANot Yet Recruiting
NCT07317427PhilipsPrecise Image for Interventional CT

Precise Image for Interventional CT

Start: Jan 2026Est. completion: Oct 202655 patients
N/ANot Yet Recruiting
NCT07317453PhilipsPrecise Image for Musculoskeletal CT

Precise Image for Musculoskeletal CT

Start: Jan 2026Est. completion: Oct 202684 patients
N/ANot Yet Recruiting
NCT07317479PhilipsClinical Study for P-MAR

Clinical Study for P-MAR

Start: Jan 2026Est. completion: Oct 2026120 patients
N/ANot Yet Recruiting
NCT07317466PhilipsPrecise Image for Pediatrics

Precise Image for Pediatrics

Start: Jan 2026Est. completion: Sep 2026168 patients
N/ANot Yet Recruiting
NCT03875469BayerCentargo injector

Study to Test the Usability of a New Injector to Administer Contrast Media Into Humans for Diagnostic Purposes

Start: Jun 2019Est. completion: Mar 2020425 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs, potential near-term approvals
3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.